Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DORM
DORM logo

DORM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Dorman Products Inc (DORM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
104.360
1 Day change
1.76%
52 Week Range
166.890
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Dorman Products Inc (DORM) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has seen recent analyst upgrades and positive commentary on its long-term growth potential, the financial performance in the latest quarter shows significant declines in net income and EPS, which could indicate underlying challenges. Additionally, technical indicators and trading sentiment do not provide a compelling entry point at this time.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum, but the RSI is neutral at 57.637, showing no clear signal. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting a downward trend. Support is at 99.59, and resistance is at 108.326.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
5

Positive Catalysts

  • Analyst upgrades from Jefferies and Roth Capital, citing long-term growth visibility and attractive entry points. Light Duty demand remains robust, and Heavy Duty demand shows signs of recovery.

Neutral/Negative Catalysts

  • Significant declines in net income (-78.79% YoY) and EPS (-78.53% YoY) in the latest quarter. The stock is trading below key moving averages, indicating weak technical momentum. No recent news or event-driven catalysts.

Financial Performance

In Q4 2025, revenue increased by 0.78% YoY to $537.93M, but net income dropped significantly by 78.79% YoY to $11.56M. EPS also fell by 78.53% YoY to 0.38. Gross margin improved slightly to 42.59%, up 2.53% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets but maintain positive ratings. Roth Capital reduced its target to $162 from $182, Jefferies upgraded the stock to Buy with a target of $140, and Barrington lowered its target to $150 from $180-$190. Analysts highlight long-term growth potential but acknowledge short-term challenges.

Wall Street analysts forecast DORM stock price to rise
2 Analyst Rating
Wall Street analysts forecast DORM stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 104.360
sliders
Low
150
Averages
165
High
180
Current: 104.360
sliders
Low
150
Averages
165
High
180
Roth Capital
Buy
downgrade
$182 -> $162
AI Analysis
2026-03-02
Reason
Roth Capital
Price Target
$182 -> $162
AI Analysis
2026-03-02
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Dorman Products to $162 from $182 and keeps a Buy rating on the shares. The company reported better than expected Q4 results but lower than expected FY26 guidance, the analyst tells investors in a research note. Light Duty demand continues to be robust, while Heavy Duty seems to have turned the corner and Specialty remains steady, the firm added.
Jefferies
Hold
to
Buy
upgrade
$159 -> $140
2026-03-02
Reason
Jefferies
Price Target
$159 -> $140
2026-03-02
upgrade
Hold
to
Buy
Reason
Jefferies upgraded Dorman Products to Buy from Hold with a price target of $140, down from $159. The firm believes the stock's recent underperformance has created an attractive entry point. The shares are trading at an historical discount after the "downbeat" Q1 guidance, despite it posting recent record margins, strong cash generation, and "clear" long-term growth visibility, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DORM
Unlock Now

People Also Watch